United States
FDA Grants Orphan Drug Status to Ultimovacs' UV1 Cancer Vaccine for Mesothelioma Treatment
Ultimovacs ASA , a clinical-stage biotechnology leader in novel immunothera...
Nursa raised $80.0M in a Series B round by Drive Capital.
Nursa, a nationwide platform that exists to put a nurse at the bedside of e...
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Nascent Biotech, Inc., a clinical-stage biotechnology Company whose busines...
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008, a novel monoclonal antibody drug against multiple solid cancers
Zumutor Biologics Inc , a Boston based biopharmaceutical company focused on...
Yield10 Bioscience Announces Closing of $3.7 Million Public Offering
Yield10 Bioscience, Inc., an agricultural bioscience company, announc...
ABVC BioPharma to open new facility in Taiwan for manufacturing retinal surgery device
US-based ABVC BioPharma has received approval from the Science Park Adminis...
First Stop Health Celebrates One Year of Virtual Primary Care
First Stop Health, a leading virtual care company for primary, urgent and m...
UnitedHealthcare Now Covers Gynesonics' Incision-Free Sonata Procedure for Uterine Fibroids Treatment
Gynesonics, Inc. a women’s healthcare company focused on the developm...
BioPharma Connections Adds LGM Pharma as a Strategic Client Partner
LGM Pharma has engaged BioPharma Connections to assist with their...
Vytalize Health Launches Charitable Initiative to Relieve Medical Debt Burden
Vytalize Health, a leading provider enablement platform, announced a new ch...
Gradia Health Raises $4.2M in Seed Funding
Gradia Health, a San Francisco, CA-based provider of an integrated concierg...
Herself Health, providing primary care to women 65 and over, raises $26M
Herself Health joins a group of startups also solving for senior care, incl...
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
Neuronetics Inc., a commercial stage medical technology company focused on ...
Novartis acquires RNA medicine delivery startup DTx Pharma for $500 M
DTx Pharma, a US-based preclinical stage biotechnology startup addressing t...
Revolutionary Next-Gen Access Instruments for Chronic Low Back Pain Treatment Unveiled by Relievant Medsystems
Relievant Medsystems, a company dedicated to transforming the diagnosis and...
InnoCare and ArriVent Announce Clinical Development Collaboration
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatm...
Petros Pharmaceuticals Announces Capital Raise of $15 Million
Petros Pharmaceuticals, Inc., a pioneer in expanding consumer access to med...
AXIM Biotechnologies Launches Revenue-Generating IgE Diagnostic Validation Assays Nationwide
AXIM Biotechnologies, an international healthcare diagnostic solutions deve...
